ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 143 filers reported holding ASCENDIS PHARMA A/S in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $65,281,832 | -36.9% | 478,676 | -30.0% | 0.08% | -38.4% |
| Q1 2024 | $103,411,179 | +62.3% | 684,072 | +35.2% | 0.14% | +53.3% |
| Q4 2023 | $63,724,038 | +33.4% | 505,947 | -0.8% | 0.09% | +15.4% |
| Q3 2023 | $47,766,647 | +7.7% | 510,109 | +2.7% | 0.08% | +13.0% |
| Q2 2023 | $44,346,757 | -11.3% | 496,882 | +6.5% | 0.07% | -18.8% |
| Q1 2023 | $50,004,452 | -7.0% | 466,372 | +5.9% | 0.08% | -15.0% |
| Q4 2022 | $53,772,875 | -18.4% | 440,292 | -31.0% | 0.10% | -21.9% |
| Q3 2022 | $65,881,000 | +8.6% | 638,001 | -2.3% | 0.13% | +12.3% |
| Q2 2022 | $60,677,000 | -0.5% | 652,724 | +25.6% | 0.11% | +25.3% |
| Q1 2022 | $60,982,000 | -4.8% | 519,612 | +9.1% | 0.09% | +15.2% |
| Q4 2021 | $64,057,000 | -4.6% | 476,154 | +13.0% | 0.08% | -20.2% |
| Q3 2021 | $67,139,000 | +23.8% | 421,227 | +2.1% | 0.10% | +20.7% |
| Q2 2021 | $54,252,000 | +39.2% | 412,411 | +36.4% | 0.08% | +22.4% |
| Q1 2021 | $38,975,000 | +400.4% | 302,422 | +547.7% | 0.07% | +378.6% |
| Q4 2020 | $7,788,000 | +31.3% | 46,694 | +21.5% | 0.01% | +16.7% |
| Q3 2020 | $5,933,000 | +71.1% | 38,441 | +64.0% | 0.01% | +50.0% |
| Q2 2020 | $3,467,000 | +373.6% | 23,440 | +277.2% | 0.01% | +300.0% |
| Q1 2019 | $732,000 | – | 6,215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |